Trademark: 86605527
Word

Status
Dead
Status Code
710
Status Date
Friday, October 20, 2023
Serial Number
86605527
Registration Number
5173984
Registration Date
Tuesday, April 4, 2017
Mark Type
2000
Filing Date
Wednesday, April 22, 2015
Published for Opposition
Tuesday, December 13, 2016
Cancellation Date
Friday, October 20, 2023

Trademark Owner History

Classifications
5 Vitamin preparations; medicines for human purposes for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, and adrenocortical insufficiency; capsules for pharmaceutical purposes for the treatment of hypertension, hyperlipidemia, schizophrenia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystiti; pharmaceutical preparations for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, community-acquired pneumonia, urogenital tract infection, endocarditis, bacterial infection, meningitis, and granulocytopenia; chemico-pharmaceutical preparations for the treatment of cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Hematologic Disorders, humanases, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, Lower respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis, bacteremia, community-acquired pneumonia, gynecological infections, urogenital tract infection, endocarditis, bacterial infection,, meningitis, and granulocytopenia; analgesics; drugs for medical purposes for the treatment of cancers, the prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, Bacterial septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, bacteremia, community-acquired pneumonia, septicemia, urogenital tract infection, endocarditis, bacterial infection, urinary tract infection, meningitis, granulocytopenia, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency; capsules for medicines sold empty; sedatives; tranquillizers; biological preparations for medical purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; chemical preparations for pharmaceutical purposes for the treatment of cancers, prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Community-acquired pneumonia, Nosocomial pneumonia, intra-abdominal infections, Skin and skin structure infections, endocarditis, pneumonia, urinary tract infection, Gynecological infections, meningitis, septicemia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis; chemical preparations for medical purposes for the treatment of cancers, the prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Community-acquired pneumonia, Nosocomial pneumonia, Pseudomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, Streptococcus anginosus, Streptococcus intermadius, Streptococcus constellatus, bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, clostridium perfringens, Peptostreptococcus micros, urogenital tract infection, endocarditis, pneumonia, urinary tract infection, Gynecological infections meningitis, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis; antibiotics; Injectable pharmaceuticals for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, community-acquired pneumonia, urogenital tract infection, endocarditis, bacterial infection, meningitis, and granulocytopenia; Bulk drugs, namely, active pharmaceutical preparations for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia; biochemical medicines for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; blood products, namely, blood and blood plasma; Tinctures, namely, pharmaceutical preparations deriving from crude drugs being immersed in alcohol for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; radium for medical purposes; radioactive substances for use in nuclear medicine; isotopes for medical purposes; radioactive substances for medical purposes; oxygen baths preparations for medical use; gases for medical use; oxygen for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants for hygienic purposes; disinfectants; contact lens solution; contact lens cleaning preparations; cleaning solutions for use with contact lenses; bacteriological culture mediums; bouillons for bacteriological cultures; nutritive substances for microorganisms for medical purposes; cultures of microorganisms for medical and veterinary use; dietetic pasta, crackers and sugar for medical use; nutritional supplements; food for babies; infant milk powder; air purifying preparations; disinfectants for chemical toilets; medicines for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; biological preparations for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; chemical preparations for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; dietary supplements for animals; pesticides; vermin destroying preparations; disinfectant wipes; wadding for medical purposes; dental abrasives; dental mastics
35 Retail and wholesale store services featuring medicines; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring sanitary preparations
The mark consists of two Chinese characters.
Color is not claimed as a feature of the mark.
The transliteration of the Chinese characters in the mark is "Hui Zheng." Hui means "brightness" and "Zheng" means "upright."

Trademark Events
Oct 20, 2023
Cancelled Sec. 8 (6-Yr)
Apr 4, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 27, 2019
Teas Change Of Correspondence Received
Sep 19, 2018
Automatic Update Of Assignment Of Ownership
Apr 4, 2017
Registered-Principal Register
Feb 28, 2017
1(B) Basis Deleted; Proceed To Registration
Feb 17, 2017
Notice Of Allowance Cancelled
Feb 27, 2017
Case Assigned To Intent To Use Paralegal
Feb 17, 2017
Teas Delete 1(B) Basis Received
Feb 7, 2017
Noa E-Mailed - Sou Required From Applicant
Dec 13, 2016
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2016
Published For Opposition
Nov 23, 2016
Notification Of Notice Of Publication E-Mailed
Nov 2, 2016
Approved For Pub - Principal Register
Nov 2, 2016
Examiner's Amendment Entered
Nov 2, 2016
Notification Of Examiners Amendment E-Mailed
Nov 2, 2016
Examiners Amendment E-Mailed
Nov 2, 2016
Examiners Amendment -Written
Oct 13, 2016
Previous Allowance Count Withdrawn
Oct 4, 2016
Withdrawn From Pub - Og Review Query
Sep 15, 2016
Approved For Pub - Principal Register
Aug 25, 2016
Teas/Email Correspondence Entered
Aug 24, 2016
Correspondence Received In Law Office
Aug 24, 2016
Teas Request For Reconsideration Received
Feb 24, 2016
Notification Of Final Refusal Emailed
Feb 24, 2016
Final Refusal E-Mailed
Feb 24, 2016
Final Refusal Written
Jan 30, 2016
Teas/Email Correspondence Entered
Jan 29, 2016
Correspondence Received In Law Office
Jan 29, 2016
Teas Response To Office Action Received
Aug 3, 2015
Notification Of Non-Final Action E-Mailed
Aug 3, 2015
Non-Final Action E-Mailed
Aug 3, 2015
Non-Final Action Written
Aug 1, 2015
Assigned To Examiner
May 2, 2015
Notice Of Design Search Code E-Mailed
May 1, 2015
New Application Office Supplied Data Entered
Apr 25, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24